The U.S. District Court for the District of Massachusetts has entered final judgments against California resident Kevin C. Dills and two entities that Dills controlled.
The Securities and Exchange Commission (SEC) charged Dills and Joseph Padilla in June 2023 for their roles in a fraudulent stock selling scheme.
According to the complaint, Padilla engaged in a fraudulent scheme for his own benefit and also on behalf of individuals who paid Padilla to arrange illegal stock sales.
The complaint alleges that those individuals hid their identities by selling stock through offshore accounts in different names that Padilla arranged.
From early 2020 into 2022, Dills allegedly conspired with Padilla to sell stock of Oncology Pharma, Inc., a company that Dills secretly controlled, while avoiding legal requirements…
Read More